Bibliographic Details
| Title: |
Contrast-Induced Encephalopathy: A Case Series Analysis. |
| Authors: |
Stebner, Alexander1,2,3, Bosshart, Salome1,2, Hainc, Nicolin4, Nierobisch, Nathalie4, Zedde, Marialuisa5, Pascarella, Rosario5, Goyal, Mayank1,2, Ospel, Johanna1,2 johannaospel@gmail.com |
| Source: |
Annals of Indian Academy of Neurology. Jul/Aug2024, Vol. 27 Issue 4, p403-407. 5p. |
| Subject Terms: |
*IODINE radioisotopes, *RESEARCH funding, *ENDOVASCULAR aneurysm repair, *COMPUTED tomography, *BRAIN diseases, *ENDOVASCULAR surgery, *PREDNISOLONE, *RETROSPECTIVE studies, *CASE studies, *CORONARY angiography |
| Abstract: |
Background: Contrast-induced encephalopathy (CIE) is a rare adverse event linked to intravascular use of iodine-containing contrast media. The prevalence of CIE could increase in the future due to growing numbers of endovascular procedures. We provide insights from a case series of 7 patients. Methods: Cases from 3 centers were collected based on existing academic collaborations, and key factors were extracted to illustrate development and management of CIE. Results: In our retrospective case-series analysis of 7 cases from 3 countries, affected patients had an equal distribution of sex (4 women, 3 men) and a median age of 75 (IQR 63-77). Common risk factors included hypertension (5/7), hyperlipidemia (5/7), previous stroke (3/7), and type 2 diabetes (3/7). CIE developed in 3 cases after endovascular thrombectomy (EVT) for stroke, in 2 cases after aneurysm treatment, in 1 case after cardiac catheterization, and in 1 case after diagnostic computed tomography (CT) angiography without an endovascular procedure. The median procedure time was 48 min (IQR 40-81). All patients received non-ionic, low-osmolar contrast agents with volumes ranging from 100-300 ml. Symptom onset was close to contrast administration, with stroke-like neurological deficits being most common (4/7). Prednisolone was the most frequently used medication to treat the symptoms (4/7). Symptom resolution occurred in 4 out of 7 patients within two to several days, and 1 patient died, but without clear connection to CIE. Conclusion: CIE is a rare and possibly underrecognized condition, but fortunately, with a favorable outcome in most cases. [ABSTRACT FROM AUTHOR] |
|
Copyright of Annals of Indian Academy of Neurology is the property of Wolters Kluwer India Pvt Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Complete |
